[HTML][HTML] Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy

E Brogi, M Krystel-Whittemore - Modern Pathology, 2021 - Elsevier
Papillary neoplasms of the breast are a heterogeneous group of epithelial tumors nearly
entirely composed of papillae. Their classification rests on the characteristics of the …

[HTML][HTML] High-risk and selected benign breast lesions diagnosed on core needle biopsy: Evidence for and against immediate surgical excision

A Harbhajanka, HL Gilmore, BC Calhoun - Modern Pathology, 2022 - Elsevier
The vast majority of image-detected breast abnormalities are diagnosed by percutaneous
core needle biopsy (CNB) in contemporary practice. For frankly malignant lesions …

Intraductal Papillomas.

SN Tierney - The Surgical Clinics of North America, 2022 - europepmc.org
The most common manifestation of papillary breast disease is intraductal papilloma (IDP).
As breast disease management becomes more refined, increasing attention has been …

[HTML][HTML] The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma

T Kader, K Elder, M Zethoven, T Semple, P Hill… - NPJ Breast …, 2020 - nature.com
Intraductal papillomas (IDP) are challenging breast findings because of their variable risk of
progression to malignancy. The molecular events driving IDP development and genomic …

Benign breast intraductal papillomas without atypia at core needle biopsies: is surgical excision necessary?

T Moseley, B Desai, GJ Whitman, EK Robinson… - Annals of surgical …, 2021 - Springer
Purpose The aim of this study was to determine the upgrade rate of image-guided core
needle biopsy (CNB)-proven benign breast intraductal papillomas (IDPs) without atypia to …

Surgical excision versus clinical follow-up: Outcomes of benign intraductal papillomas diagnosed on core needle biopsy

Z Jin, N Al Qaysi, M Hanna, V Moses, L Spiguel… - The American Journal of …, 2024 - Elsevier
Objective To compare outcomes between benign intraductal papillomas diagnosed on core
need biopsy that were excised (BIP-E) versus those that were followed-up (BIP-F) at our …

Treatment strategy for breast benign intraductal papilloma: A Meta-Analysis

C Lou, W Wang, B Zhou - Journal of Environmental Pathology …, 2024 - dl.begellhouse.com
Currently, the optimal treatment approach for breast benign intraductal papilloma (IDP)
diagnosed via biopsy remains uncertain. There is ongoing debate regarding the feasibility of …

[HTML][HTML] Management of Breast Intraductal Papilloma Diagnosed on Core Needle Biopsy: Excision or Follow-up?

M Gillani, R Idress, S Afzal, M Khan, H Shahzad… - Cureus, 2024 - ncbi.nlm.nih.gov
Methods The study is a retrospective review of patient records from 2012 to 2019, at a
tertiary care hospital in Pakistan. Data was analyzed using Statistical Package for Social …

Upgrade Rısk on Core Needle Bıopsy, Should we Contınue Excısıon of the Papıllomas of the Breast?

R Ucak, C Tanik, N Polat, C Sahin, C Kaya… - Indian Journal of …, 2023 - Springer
Uncertainties in the clinical management of breast papillomas is still persisting. The aim of
this study is to determine the histological upgrade and malignancy upgrade rate in excisions …

[HTML][HTML] Can we now reach a consensus on the management of benign papillary breast lesions?

S Khan, HD Bear - Annals of Breast Surgery, 2019 - abs.amegroups.org
Management of benign breast lesions diagnosed by core needle biopsy (CNB) remains a
controversial topic. Specifically, there is no consensus on the management of intraductal …